Join

Compare · SUNL vs SWKH

SUNL vs SWKH

Side-by-side comparison of Sunlight Financial Holdings Inc. (SUNL) and SWK Holdings Corporation (SWKH): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both SUNL and SWKH operate in Diversified Financial Services (Finance), so they compete in similar markets.
  • SWKH is the larger of the two at $242.4M, about 1.1x SUNL ($223.9M).
  • SUNL has more recent analyst coverage (7 ratings vs 2 for SWKH).
MetricSUNLSWKH
Company
Sunlight Financial Holdings Inc.
SWK Holdings Corporation
Price
$1.25-28.16%
$15.92-6.46%
Market cap
$223.9M
$242.4M
1M return
-
-2.45%
1Y return
-
+10.98%
Industry
Diversified Financial Services
Diversified Financial Services
Exchange
NYSE
NASDAQ
IPO
2021
News (4w)
0
0
Recent ratings
7
2
SUNL

Sunlight Financial Holdings Inc.

Sunlight Financial Holdings Inc. operates a business-to-business-to-consumer, technology-enabled point-of-sale financing platform that serves residential solar and home improvement contractors in the United States. Its platform is used to provide homeowners secured and unsecured loans, originated by third-party lenders, for the purchase and installation of residential solar energy systems and other home improvements. The company was incorporated in 2014 and is based in New York, New York.

SWKH

SWK Holdings Corporation

SWK Holdings Corporation, a specialty finance company, focuses on the healthcare sector. The company operates in two segments, Finance Receivables and Pharmaceutical Development. It provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors. The company, through its subsidiary, SWK Advisors LLC, offers non-discretionary investment advisory services to institutional clients in separately managed accounts to invest in life science finance. The company also engages in the pharmaceutical development, formulation and manufacturing, and licensing business through the Peptelligence platform. Its product pipeline includes Ovarest, an oral leuprolide tablet to treat endometriosis; and Tobrate, an oral tobramycin tablet for the treatment of uncomplicated urinary tract infections. The company was formerly known as Kana Software, Inc. and changed its name to SWK Holdings Corporation in December 2009. SWK Holdings Corporation was incorporated in 1996 and is headquartered in Dallas, Texas.

Latest SUNL

Latest SWKH